SLShaun S. X. Lim

Shaun S. X. Lim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shaun S. X. Lim has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Connectomic dopamine-neuron disinhibition accelerates behavioral extinction

    by Sasha C.V. Burwell, Rene K. Carter, Haidun Yan, Shaun S.X. Lim, Brenda C. Shields, Michael R Tadross

    Animals must balance persistence with flexibility when outcomes change. Behavioral extinction—the reduction in responding to cues that no longer predict reward—is widely thought to be driven by pauses in dopamine-neuron firing upon omission of expected rewards. However, whether these pauses are necessary remains unknown. We used a connectomic intervention to weaken inhibitory synapses onto dopamine neurons in the ventral tegmental area, attenuating electrophysiologically defined pauses while sparing tonic and burst firing. Contrary to canonical accounts, this intervention accelerated rather than delayed behavioral extinction, demonstrating that these synapses normally postpone behavioral extinction. Learning about a newly rewarded cue was spared, arguing against a general disruption of learning. Dopamine photometry showed that the intervention attenuated reward-omission dopamine dips, whose dissipation preceded and predicted behavioral extinction across mice. These findings show that pause-generating inhibitory inputs to dopamine neurons sustain behavioral persistence. This mechanism may protect established associations from premature abandonment as outcomes fluctuate.

  • A cholinergic hub in the nucleus accumbens gates opioid-reward learning

    by S. Aryana Yousefzadeh, Haidun Yan, Seung-Hwa Kwak, Yunju Oh, Pyeonghwa Jeong, Vladimir Pogorelov, J. Russell Ravenel, Shaun S. X. Lim, James M. Roach, Brenda C. Shields, et al.


  • DART.2: bidirectional synaptic pharmacology with thousandfold cellular specificity

    by Brenda C. Shields, Haidun Yan, Shaun S. X. Lim, Sasha C. V. Burwell, Celine M. Cammarata, Elizabeth A. Fleming, S. Aryana Yousefzadeh, Victoria Z. Goldenshtein, Elizabeth W. Kahuno, Purav P. Vagadia, et al.

    Precision pharmacology aims to manipulate specific cellular interactions within complex tissues. In this pursuit, we introduce DART.2 (drug acutely restricted by tethering), a second-generation cell-specific pharmacology technology. The core advance is optimized cellular specificity—up to 3,000-fold in 15 min—enabling the targeted delivery of even epileptogenic drugs without off-target effects. Additionally, we introduce brain-wide dosing methods as an alternative to local cannulation and tracer reagents for brain-wide dose quantification. We describe four pharmaceuticals—two that antagonize excitatory and inhibitory postsynaptic receptors, and two that allosterically potentiate these receptors. Their versatility is showcased across multiple mouse-brain regions, including cerebellum, striatum, visual cortex and retina. Finally, in the ventral tegmental area, we find that blocking inhibitory inputs to dopamine neurons accelerates locomotion, contrasting with previous optogenetic and pharmacological findings. Beyond enabling the bidirectional perturbation of chemical synapses, these reagents offer intersectional precision—between genetically defined postsynaptic cells and neurotransmitter-defined presynaptic partners.


  • Open Access

    Natural phasic inhibition of dopamine neurons signals cognitive rigidity

    by Sasha C.V. Burwell, Haidun Yan, Shaun S.X. Lim, Brenda C. Shields, Michael R. Tadross

    When animals unexpectedly fail, their dopamine neurons undergo phasic inhibition that canonically drives extinction learning—a cognitive-flexibility mechanism for discarding outdated strategies. However, the existing evidence equates natural and artificial phasic inhibition, despite their spatiotemporal differences. Addressing this gap, we targeted a GABA A -receptor antagonist precisely to dopamine neurons, yielding three unexpected findings. First, this intervention blocked natural phasic inhibition selectively, leaving tonic activity unaffected. Second, blocking natural phasic inhibition accelerated extinction learning—opposite to canonical mechanisms. Third, our approach selectively benefitted perseverative mice, restoring rapid extinction without affecting new reward learning. Our findings reveal that extinction learning is rapid by default and slowed by natural phasic inhibition—challenging foundational learning theories, while delineating a synaptic mechanism and therapeutic target for cognitive rigidity.